Papapetropoulos Spyros
CIK 0001832694
President and CEODirector
Filings
10
Latest Sep 2, 2025
Issuers covered
3
Showing
10 of 10
Page 1
Track record
Realized signed returns on open-market buys and sales
No scored trades yet for Papapetropoulos Spyros. Track record appears once open-market purchases or sales reach the +30 day horizon.
Issuers
Companies where Papapetropoulos Spyros has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| LPCN | Lipocine Inc. | 5 | Jun 5, 2025 |
| NEUP | Neuphoria Therapeutics Inc. | 3 | Sep 2, 2025 |
| VIGL | Vigil Neuroscience, Inc. | 2 | May 4, 2022 |
All filings
10 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|